论文部分内容阅读
报道该院肝胆外科与瑞典Ｌｕｎｄ大学合作的一项临床前瞻性研究。作者将１９９４年２月至１９９５年４月期间入院的４０例经手术及病理证实为不可切除的肝细胞型肝癌（ＨＣＣ）患者随机分成二组，重复暂时性去肝动脉化（ＲＴＤ组）及肝动脉结扎（ＨＡＬ组）各２０例；对二组病人的术后过程、肝功能变化、影象学检查、生存期、存活率等进行比较。结果表明：ＲＴＤ组均优于ＨＡＬ组，ＲＴＤ组有效率７０％，术后中位生存期８．２个月，术后６个月存活率７９．７％；而ＨＡＬ组有效率仅５％，术后中位生存期５．１个月，术后６个月存活率３５．８％。文内详细介绍ＲＴＤ的实施方法、病人对治疗的反应及处理，认为ＲＴＤ具有缺血、防止侧支循环建立和派生氧自由基三重作用，疗效明显优于ＨＡＬ，是一种有前景的肝癌外科缺血疗法，值得进一步的研究、推广和应用。
A clinical prospective study of hepatobiliary surgery in the hospital and Lund University in Sweden was reported. The authors randomly assigned 40 patients with unresectable hepatocellular carcinoma (HCC) who had undergone surgery and pathology from February 1994 to April 1995 to be randomly divided into two groups to repeat temporary dearterialization (RTD) and Twenty patients in each group received hepatic artery ligation (HAL group); postoperative course, liver function changes, imaging examination, survival time, and survival rate of the two groups were compared. The results showed that the RTD group was superior to the HAL group, the RTD group had an effective rate of 70%, the median postoperative survival period was 8.2 months, and the survival rate was 79.7% at 6 months postoperatively; while the HAL group had only 5% efficiency. The median postoperative survival time was 5.1 months, and the survival rate was 35.8% after 6 months. The article describes in detail the implementation of RTD, patient response to treatment and treatment, that RTD has ischemia, to prevent the establishment of collateral circulation and derived oxygen free radical triple effect, the effect is significantly better than HAL, is a promising surgical liver cancer Ischemic therapy deserves further research, promotion and application.